Announcements Trials
Browse Landscape

Phase

Phase 2 87Phase 1 54Phase 1/2 37Phase 3 19Phase EARLY_PHASE1 4Phase NA 3Phase 4 3Phase 2/3 2

Status

Completed 3Terminated 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 2Neoplasm, Residual 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × aldesleukin × Clear all
NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Novartis

Phase 4 Completed
26 enrolled 7 charts
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT01347996 2017-11-29

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

Cytovia, Inc.

Phase 4 Completed
84 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT00006864 2014-01-09

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Case Comprehensive Cancer Center

Phase 4 Completed
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡